Trial Profile
A multicenter, open-label, pilot trial to evaluate the effectiveness and safety of Enbrel in combination with narrowband UVB phototherapy for the treatment of psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 May 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 21 Sep 2008 Actual end date (1 Mar 2006) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2008 New trial record.